ReP USP - Resultado da busca

Artigo de periodico
Paediatric sepsis survivors are resistant to sepsis‐induced long‐term immune dysfunction (2024)
Morelo, David Fernando Colon ; Wanderley, Carlos Wagner de Souza ; Turato, Walter Miguel; Borges, Vanessa F.; Franchin, Marcelo; Castanheira, Fernanda Vargas e Silva; Nascimento, Daniele Carvalho Bernardo; Prado, Douglas da Silva; Lima, Mikhael Haruo Fernandes de ; Volpon, Leila Costa; Kavaguti, Silvia K.; Carlotti, Ana Paula de Carvalho Panzeri ; Carmona, Fabio ; Franklin, Bernardo S.; Cunha, Thiago Mattar ; Alves Filho, José Carlos Farias ; Cunha, Fernando de Queiroz
Source: British Journal of Pharmacology. Unidades: FCF, FMRP
Subjects: MACRÓFAGOS, SEPSE, CRIANÇAS, IMUNOSSUPRESSÃO, SISTEMA IMUNE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MORELO, David Fernando Colon et al. Paediatric sepsis survivors are resistant to sepsis‐induced long‐term immune dysfunction. British Journal of Pharmacology, v. 181, n. 8, p. 1308-1323, 2024Tradução . . Disponível em: https://doi.org/10.1111/bph.16286. Acesso em: 06 jul. 2024.
APA
Morelo, D. F. C., Wanderley, C. W. de S., Turato, W. M., Borges, V. F., Franchin, M., Castanheira, F. V. e S., et al. (2024). Paediatric sepsis survivors are resistant to sepsis‐induced long‐term immune dysfunction. British Journal of Pharmacology, 181( 8), 1308-1323. doi:10.1111/bph.16286
NLM
Morelo DFC, Wanderley CW de S, Turato WM, Borges VF, Franchin M, Castanheira FV e S, Nascimento DCB, Prado D da S, Lima MHF de, Volpon LC, Kavaguti SK, Carlotti AP de CP, Carmona F, Franklin BS, Cunha TM, Alves Filho JCF, Cunha F de Q. Paediatric sepsis survivors are resistant to sepsis‐induced long‐term immune dysfunction [Internet]. British Journal of Pharmacology. 2024 ; 181( 8): 1308-1323.[citado 2024 jul. 06 ] Available from: https://doi.org/10.1111/bph.16286
Vancouver
Morelo DFC, Wanderley CW de S, Turato WM, Borges VF, Franchin M, Castanheira FV e S, Nascimento DCB, Prado D da S, Lima MHF de, Volpon LC, Kavaguti SK, Carlotti AP de CP, Carmona F, Franklin BS, Cunha TM, Alves Filho JCF, Cunha F de Q. Paediatric sepsis survivors are resistant to sepsis‐induced long‐term immune dysfunction [Internet]. British Journal of Pharmacology. 2024 ; 181( 8): 1308-1323.[citado 2024 jul. 06 ] Available from: https://doi.org/10.1111/bph.16286
Artigo de periodico
Sex- and age-specific respiratory alterations induced by prenatal exposure to the cannabinoid receptor agonist WIN 55,212-2 in rats (2023)
Patrone, Luís Gustavo A.; Ferrari, Gustavo Duarte ; Silva, Rodrigo Moreira da ; Alberici, Luciane Carla ; Lopes, Norberto Peporine ; Stabile, Angelita Maria ; Klein, Wilfried ; Bícego, Kênia C.; Gargaglioni, Luciane H.
Source: British Journal of Pharmacology. Unidades: FCFRP, EERP, FFCLRP
Subjects: RECEPTORES, CANABINOIDES, GRAVIDEZ, TRONCO CEREBRAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PATRONE, Luís Gustavo A. et al. Sex- and age-specific respiratory alterations induced by prenatal exposure to the cannabinoid receptor agonist WIN 55,212-2 in rats. British Journal of Pharmacology, v. 180, n. 13, p. 1-24, 2023Tradução . . Disponível em: https://doi.org/10.1111/bph.16044. Acesso em: 06 jul. 2024.
APA
Patrone, L. G. A., Ferrari, G. D., Silva, R. M. da, Alberici, L. C., Lopes, N. P., Stabile, A. M., et al. (2023). Sex- and age-specific respiratory alterations induced by prenatal exposure to the cannabinoid receptor agonist WIN 55,212-2 in rats. British Journal of Pharmacology, 180( 13), 1-24. doi:10.1111/bph.16044
NLM
Patrone LGA, Ferrari GD, Silva RM da, Alberici LC, Lopes NP, Stabile AM, Klein W, Bícego KC, Gargaglioni LH. Sex- and age-specific respiratory alterations induced by prenatal exposure to the cannabinoid receptor agonist WIN 55,212-2 in rats [Internet]. British Journal of Pharmacology. 2023 ; 180( 13): 1-24.[citado 2024 jul. 06 ] Available from: https://doi.org/10.1111/bph.16044
Vancouver
Patrone LGA, Ferrari GD, Silva RM da, Alberici LC, Lopes NP, Stabile AM, Klein W, Bícego KC, Gargaglioni LH. Sex- and age-specific respiratory alterations induced by prenatal exposure to the cannabinoid receptor agonist WIN 55,212-2 in rats [Internet]. British Journal of Pharmacology. 2023 ; 180( 13): 1-24.[citado 2024 jul. 06 ] Available from: https://doi.org/10.1111/bph.16044
Trabalho de evento-resumo periodico
Selective role of eNOS on the chronotropic effect of endogenous 6-nitrodopamine (6-ND) in mice isolated atria (2023)
Fuguhara, Vivian ; Britto Júnior, José ; Antunes, Edson ; Campos, Rafael; De Nucci, Gilberto ; Cunha, Fernando; Chiavegatto, Silvana
Source: British Journal of Pharmacology. Conference titles: World Congress of Basic & Clinical Pharmacology. Unidade: ICB
Subjects: FARMACOLOGIA, FARMACOLOGIA CLÍNICA, ÁTRIOS DO CORAÇÃO, MICROTUBOS, CAMUNDONGOS, MODELOS ANIMAIS DE DOENÇAS, FREQUÊNCIA CARDÍACA, CANAIS IÔNICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FUGUHARA, Vivian et al. Selective role of eNOS on the chronotropic effect of endogenous 6-nitrodopamine (6-ND) in mice isolated atria. British Journal of Pharmacology. Oxford: John Wiley & Sons Ltd. Disponível em: https://doi.org/10.1111/bph.16105. Acesso em: 06 jul. 2024. , 2023
APA
Fuguhara, V., Britto Júnior, J., Antunes, E., Campos, R., De Nucci, G., Cunha, F., & Chiavegatto, S. (2023). Selective role of eNOS on the chronotropic effect of endogenous 6-nitrodopamine (6-ND) in mice isolated atria. British Journal of Pharmacology. Oxford: John Wiley & Sons Ltd. doi:10.1111/bph.16105
NLM
Fuguhara V, Britto Júnior J, Antunes E, Campos R, De Nucci G, Cunha F, Chiavegatto S. Selective role of eNOS on the chronotropic effect of endogenous 6-nitrodopamine (6-ND) in mice isolated atria [Internet]. British Journal of Pharmacology. 2023 ; 180 156-157.[citado 2024 jul. 06 ] Available from: https://doi.org/10.1111/bph.16105
Vancouver
Fuguhara V, Britto Júnior J, Antunes E, Campos R, De Nucci G, Cunha F, Chiavegatto S. Selective role of eNOS on the chronotropic effect of endogenous 6-nitrodopamine (6-ND) in mice isolated atria [Internet]. British Journal of Pharmacology. 2023 ; 180 156-157.[citado 2024 jul. 06 ] Available from: https://doi.org/10.1111/bph.16105
Trabalho de evento-resumo periodico
Novel experimental occlusal trauma promotes comparable orofacial inflammatory painand bone loss: role of H2S-producing enzymes (2023)
Oliveira, Janaíne Prata de ; Santos, Larissa; Teixeira, Simone Aparecida ; Contin, Ivo ; Muscará, Marcelo Nicolás (Orientador) ; Costa, Soraia Katia Pereira
Source: British Journal of Pharmacology. Conference titles: World Congress of Basic & Clinical Pharmacology. Unidades: ICB, FO
Subjects: FARMACOLOGIA, FARMACOLOGIA CLINICA, OSSO E OSSOS, RATOS WISTAR, INFLAMAÇÃO, MÚSCULO MASSETER, WESTERN BLOTTING, DOR FACIAL, ENZIMAS, ATIVAÇÃO ENZIMÁTICA, OCLUSÃO DENTÁRIA TRAUMÁTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, Janaíne Prata de et al. Novel experimental occlusal trauma promotes comparable orofacial inflammatory painand bone loss: role of H2S-producing enzymes. British Journal of Pharmacology. Oxford: John Wiley & Sons Ltd. Disponível em: https://doi.org/10.1111/bph.16113. Acesso em: 06 jul. 2024. , 2023
APA
Oliveira, J. P. de, Santos, L., Teixeira, S. A., Contin, I., & Costa, S. K. P. (2023). Novel experimental occlusal trauma promotes comparable orofacial inflammatory painand bone loss: role of H2S-producing enzymes. British Journal of Pharmacology. Oxford: John Wiley & Sons Ltd. doi:10.1111/bph.16113
NLM
Oliveira JP de, Santos L, Teixeira SA, Contin I, Costa SKP. Novel experimental occlusal trauma promotes comparable orofacial inflammatory painand bone loss: role of H2S-producing enzymes [Internet]. British Journal of Pharmacology. 2023 ; 180 1254-1255.[citado 2024 jul. 06 ] Available from: https://doi.org/10.1111/bph.16113
Vancouver
Oliveira JP de, Santos L, Teixeira SA, Contin I, Costa SKP. Novel experimental occlusal trauma promotes comparable orofacial inflammatory painand bone loss: role of H2S-producing enzymes [Internet]. British Journal of Pharmacology. 2023 ; 180 1254-1255.[citado 2024 jul. 06 ] Available from: https://doi.org/10.1111/bph.16113
Trabalho de evento-resumo periodico
Effects of different antioxidant agents on the production/release of 6-nitrodopamine by human umbilical cord artery in vitro (2023)
Furlaneto, Rafael; Britto Júnior, José ; Campos, Rafael; Teixeira, Simone Aparecida ; Muscará, Marcelo Nicolás (Orientador) ; De Nucci, Gilberto
Source: British Journal of Pharmacology. Conference titles: World Congress of Basic & Clinical Pharmacology. Unidade: ICB
Subjects: FARMACOLOGIA, FARMACOLOGIA CLÍNICA, ANTIOXIDANTES, CORDÃO UMBILICAL, INIBIDORES DE ENZIMAS, RECEPTORES DE DOPAMINA, SUPERÓXIDO DISMUTASE, VASODILATAÇÃO, ANTAGONISMO DE DROGAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FURLANETO, Rafael et al. Effects of different antioxidant agents on the production/release of 6-nitrodopamine by human umbilical cord artery in vitro. British Journal of Pharmacology. Oxford: John Wiley & Sons Ltd. Disponível em: https://doi.org/10.1111/bph.16105. Acesso em: 06 jul. 2024. , 2023
APA
Furlaneto, R., Britto Júnior, J., Campos, R., Teixeira, S. A., & De Nucci, G. (2023). Effects of different antioxidant agents on the production/release of 6-nitrodopamine by human umbilical cord artery in vitro. British Journal of Pharmacology. Oxford: John Wiley & Sons Ltd. doi:10.1111/bph.16105
NLM
Furlaneto R, Britto Júnior J, Campos R, Teixeira SA, De Nucci G. Effects of different antioxidant agents on the production/release of 6-nitrodopamine by human umbilical cord artery in vitro [Internet]. British Journal of Pharmacology. 2023 ; 180 53-54.[citado 2024 jul. 06 ] Available from: https://doi.org/10.1111/bph.16105
Vancouver
Furlaneto R, Britto Júnior J, Campos R, Teixeira SA, De Nucci G. Effects of different antioxidant agents on the production/release of 6-nitrodopamine by human umbilical cord artery in vitro [Internet]. British Journal of Pharmacology. 2023 ; 180 53-54.[citado 2024 jul. 06 ] Available from: https://doi.org/10.1111/bph.16105
Trabalho de evento-resumo periodico
Novel hydrogen sulfide research approach to treat interstitial cystitis/bladder pain: role of gender differences (2023)
Santos, Larissa; Teixeira, Simone Aparecida ; Dallazen, Jorge Luiz ; Prata, Janaine; Oliveira, Mariana de; Monica, Fabiola Zakia ; Antunes, Edson ; Whiteman, Matthew; Muscará, Marcelo Nicolás (Orientador) ; Costa, Soraia Katia Pereira
Source: British Journal of Pharmacology. Conference titles: World Congressof Basic & ClinicalPharmacology. Unidade: ICB
Subjects: FARMACOLOGIA, FARMACOLOGIA CLINICA, CISTITE ANIMAL, ANTI-INFLAMATÓRIOS, DOR, CANABINOIDES, CAMUNDONGOS, INFLAMAÇÃO, CISTITE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Larissa et al. Novel hydrogen sulfide research approach to treat interstitial cystitis/bladder pain: role of gender differences. British Journal of Pharmacology. Oxford: John Wiley & Sons Ltd. Disponível em: https://doi.org/10.1111/bph.16107. Acesso em: 06 jul. 2024. , 2023
APA
Santos, L., Teixeira, S. A., Dallazen, J. L., Prata, J., Oliveira, M. de, Monica, F. Z., et al. (2023). Novel hydrogen sulfide research approach to treat interstitial cystitis/bladder pain: role of gender differences. British Journal of Pharmacology. Oxford: John Wiley & Sons Ltd. doi:10.1111/bph.16107
NLM
Santos L, Teixeira SA, Dallazen JL, Prata J, Oliveira M de, Monica FZ, Antunes E, Whiteman M, Costa SKP. Novel hydrogen sulfide research approach to treat interstitial cystitis/bladder pain: role of gender differences [Internet]. British Journal of Pharmacology. 2023 ; 180 483-484.[citado 2024 jul. 06 ] Available from: https://doi.org/10.1111/bph.16107
Vancouver
Santos L, Teixeira SA, Dallazen JL, Prata J, Oliveira M de, Monica FZ, Antunes E, Whiteman M, Costa SKP. Novel hydrogen sulfide research approach to treat interstitial cystitis/bladder pain: role of gender differences [Internet]. British Journal of Pharmacology. 2023 ; 180 483-484.[citado 2024 jul. 06 ] Available from: https://doi.org/10.1111/bph.16107
Artigo de periodico
Aryl hydrocarbon receptor (AhR) activation contributes to high‐fat diet‐induced vascular dysfunction (2022)
Silva, Josiane Fernandes da; Bolsoni, Juliana A.; Costa, Rafael Menezes da ; Alves, Juliano Vilela ; Bressan, Alecsander Fabrício Moreira ; Silva, Luiz Eduardo Virgilio da ; Costa, Tiago Januário da ; Oliveira, Antonio E. R.; Manzato, Carla Pavan; Silva, Carlos Alberto Aguiar da; Fazan Júnior, Rubens ; Cunha, Fernando de Queiroz ; Nakaya, Helder Takashi Imoto ; Carneiro, Fernando Silva ; Tostes, Rita de Cássia Aleixo
Source: British Journal of Pharmacology. Unidades: FMRP, FCF
Subjects: GORDURAS NA DIETA, CÉLULAS ENDOTELIAIS, ENDOTÉLIO VASCULAR, OBESIDADE, HIDROCARBONETOS, VASODILATAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Josiane Fernandes da et al. Aryl hydrocarbon receptor (AhR) activation contributes to high‐fat diet‐induced vascular dysfunction. British Journal of Pharmacology, v. 179, n. 12, p. 2938-2952, 2022Tradução . . Disponível em: https://doi.org/10.1111/bph.15789. Acesso em: 06 jul. 2024.
APA
Silva, J. F. da, Bolsoni, J. A., Costa, R. M. da, Alves, J. V., Bressan, A. F. M., Silva, L. E. V. da, et al. (2022). Aryl hydrocarbon receptor (AhR) activation contributes to high‐fat diet‐induced vascular dysfunction. British Journal of Pharmacology, 179( 12), 2938-2952. doi:10.1111/bph.15789
NLM
Silva JF da, Bolsoni JA, Costa RM da, Alves JV, Bressan AFM, Silva LEV da, Costa TJ da, Oliveira AER, Manzato CP, Silva CAA da, Fazan Júnior R, Cunha F de Q, Nakaya HTI, Carneiro FS, Tostes R de CA. Aryl hydrocarbon receptor (AhR) activation contributes to high‐fat diet‐induced vascular dysfunction [Internet]. British Journal of Pharmacology. 2022 ; 179( 12): 2938-2952.[citado 2024 jul. 06 ] Available from: https://doi.org/10.1111/bph.15789
Vancouver
Silva JF da, Bolsoni JA, Costa RM da, Alves JV, Bressan AFM, Silva LEV da, Costa TJ da, Oliveira AER, Manzato CP, Silva CAA da, Fazan Júnior R, Cunha F de Q, Nakaya HTI, Carneiro FS, Tostes R de CA. Aryl hydrocarbon receptor (AhR) activation contributes to high‐fat diet‐induced vascular dysfunction [Internet]. British Journal of Pharmacology. 2022 ; 179( 12): 2938-2952.[citado 2024 jul. 06 ] Available from: https://doi.org/10.1111/bph.15789
Artigo de periodico-carta/editorial
Building bridges in neuropharmacology: new therapeutic approaches for psychiatric and neurodegenerative disorders (2022)
Bailey, Alexis ; Berwick, Daniel C.; Camarini, Rosana ; Scavone, Cristoforo
Source: British Journal of Pharmacology. Unidade: ICB
Subjects: FARMACOLOGIA, NEUROFARMACOLOGIA, TRANSTORNOS MENTAIS, DOENÇAS NEURODEGENERATIVAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BAILEY, Alexis et al. Building bridges in neuropharmacology: new therapeutic approaches for psychiatric and neurodegenerative disorders. British Journal of Pharmacology. Oxford: Instituto de Ciências Biomédicas, Universidade de São Paulo. Disponível em: https://doi.org/10.1111/bph.15711. Acesso em: 06 jul. 2024. , 2022
APA
Bailey, A., Berwick, D. C., Camarini, R., & Scavone, C. (2022). Building bridges in neuropharmacology: new therapeutic approaches for psychiatric and neurodegenerative disorders. British Journal of Pharmacology. Oxford: Instituto de Ciências Biomédicas, Universidade de São Paulo. doi:10.1111/bph.15711
NLM
Bailey A, Berwick DC, Camarini R, Scavone C. Building bridges in neuropharmacology: new therapeutic approaches for psychiatric and neurodegenerative disorders [Internet]. British Journal of Pharmacology. 2022 ; 179( 8): 1475-1477.[citado 2024 jul. 06 ] Available from: https://doi.org/10.1111/bph.15711
Vancouver
Bailey A, Berwick DC, Camarini R, Scavone C. Building bridges in neuropharmacology: new therapeutic approaches for psychiatric and neurodegenerative disorders [Internet]. British Journal of Pharmacology. 2022 ; 179( 8): 1475-1477.[citado 2024 jul. 06 ] Available from: https://doi.org/10.1111/bph.15711
Artigo de periodico
Exploiting oxidized lipids and the lipid-binding GPCRs against cardiometabolic diseases (2021)
Guimaraes, Raphael C.; Gonçalves, Tiago T.; Leiria, Luiz Osório Silveira
Source: British Journal of Pharmacology. Unidade: FMRP
Subjects: ARTERIOSCLEROSE, DIABETES MELLITUS, LIPÍDEOS, OBESIDADE, RESISTÊNCIA À INSULINA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GUIMARAES, Raphael C. e GONÇALVES, Tiago T. e LEIRIA, Luiz Osório Silveira. Exploiting oxidized lipids and the lipid-binding GPCRs against cardiometabolic diseases. British Journal of Pharmacology, v. 178, n. 3, p. 531-549, 2021Tradução . . Disponível em: https://doi.org/10.1111/bph.15321. Acesso em: 06 jul. 2024.
APA
Guimaraes, R. C., Gonçalves, T. T., & Leiria, L. O. S. (2021). Exploiting oxidized lipids and the lipid-binding GPCRs against cardiometabolic diseases. British Journal of Pharmacology, 178( 3), 531-549. doi:10.1111/bph.15321
NLM
Guimaraes RC, Gonçalves TT, Leiria LOS. Exploiting oxidized lipids and the lipid-binding GPCRs against cardiometabolic diseases [Internet]. British Journal of Pharmacology. 2021 ; 178( 3): 531-549.[citado 2024 jul. 06 ] Available from: https://doi.org/10.1111/bph.15321
Vancouver
Guimaraes RC, Gonçalves TT, Leiria LOS. Exploiting oxidized lipids and the lipid-binding GPCRs against cardiometabolic diseases [Internet]. British Journal of Pharmacology. 2021 ; 178( 3): 531-549.[citado 2024 jul. 06 ] Available from: https://doi.org/10.1111/bph.15321
Artigo de periodico
TLR4 deficiency upregulates TLR9 expression and enhances irinotecan‐related intestinal mucositis and late‐onset diarrhoea (2021)
Wong, Deysi Viviana T.; Holanda, Renata Brito Falcão; Cajado, Aurilene Gomes; Bandeira, Alessandro Maia; Pereira, Jorge Fernando Brandão; Amorim, Joice Oliveira; Torres, Clarice Sampaio; Ferreira, Luana Maria Moura; Lopes, Marina Helena Silva; Oliveira, Roberta Taiane; Pereira, Anamaria Falcão; Sant'Ana, Rosane Oliveira; Arruda, Larissa Mont'alverne; Ribeiro‐Júnior, Howard Lopes; Pinheiro, Ronald Feitosa; Almeida, Paulo Roberto Carvalho; Carvalho, Robson Francisco; Chaves, Fábio Figueiredo; Rocha‐Filho, Duílio Reis; Cunha, Fernando de Queiroz ; Lima‐Júnior, Roberto César Pereira
Source: British Journal of Pharmacology. Unidade: FMRP
Subjects: DIARREIA, ANTINEOPLÁSICOS, NEOPLASIAS COLORRETAIS, MUCOSA INTESTINAL, POLIMORFISMO, NUCLEOTÍDEOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WONG, Deysi Viviana T. et al. TLR4 deficiency upregulates TLR9 expression and enhances irinotecan‐related intestinal mucositis and late‐onset diarrhoea. British Journal of Pharmacology, v. 178, n. 20, p. 4193-4209, 2021Tradução . . Disponível em: https://doi.org/10.1111/bph.15609. Acesso em: 06 jul. 2024.
APA
Wong, D. V. T., Holanda, R. B. F., Cajado, A. G., Bandeira, A. M., Pereira, J. F. B., Amorim, J. O., et al. (2021). TLR4 deficiency upregulates TLR9 expression and enhances irinotecan‐related intestinal mucositis and late‐onset diarrhoea. British Journal of Pharmacology, 178( 20), 4193-4209. doi:10.1111/bph.15609
NLM
Wong DVT, Holanda RBF, Cajado AG, Bandeira AM, Pereira JFB, Amorim JO, Torres CS, Ferreira LMM, Lopes MHS, Oliveira RT, Pereira AF, Sant'Ana RO, Arruda LM'alverne, Ribeiro‐Júnior HL, Pinheiro RF, Almeida PRC, Carvalho RF, Chaves FF, Rocha‐Filho DR, Cunha F de Q, Lima‐Júnior RCP. TLR4 deficiency upregulates TLR9 expression and enhances irinotecan‐related intestinal mucositis and late‐onset diarrhoea [Internet]. British Journal of Pharmacology. 2021 ; 178( 20): 4193-4209.[citado 2024 jul. 06 ] Available from: https://doi.org/10.1111/bph.15609
Vancouver
Wong DVT, Holanda RBF, Cajado AG, Bandeira AM, Pereira JFB, Amorim JO, Torres CS, Ferreira LMM, Lopes MHS, Oliveira RT, Pereira AF, Sant'Ana RO, Arruda LM'alverne, Ribeiro‐Júnior HL, Pinheiro RF, Almeida PRC, Carvalho RF, Chaves FF, Rocha‐Filho DR, Cunha F de Q, Lima‐Júnior RCP. TLR4 deficiency upregulates TLR9 expression and enhances irinotecan‐related intestinal mucositis and late‐onset diarrhoea [Internet]. British Journal of Pharmacology. 2021 ; 178( 20): 4193-4209.[citado 2024 jul. 06 ] Available from: https://doi.org/10.1111/bph.15609
Artigo de periodico
How environmental enrichment balances out neuroinflammation on chronic pain and comorbid depression and anxiety disorders (2021)
Vieira, Louise Faggionato Kimura ; Novaes, Leonardo Santana ; Picolo, Gisele ; Munhoz, Carolina Demarchi ; Cheung, Chi W.; Camarini, Rosana
Source: British Journal of Pharmacology. Unidade: ICB
Subjects: FARMACOLOGIA, TRANSTORNOS DA ANSIEDADE, TRANSTORNOS DO HUMOR, DEPRESSÃO, ANSIEDADE, DOR CRÔNICA, MANIFESTAÇÕES NEUROLÓGICAS, MEIO AMBIENTE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VIEIRA, Louise Faggionato Kimura et al. How environmental enrichment balances out neuroinflammation on chronic pain and comorbid depression and anxiety disorders. British Journal of Pharmacology, 2021Tradução . . Disponível em: https://doi.org/10.1111/bph.15584. Acesso em: 06 jul. 2024.
APA
Vieira, L. F. K., Novaes, L. S., Picolo, G., Munhoz, C. D., Cheung, C. W., & Camarini, R. (2021). How environmental enrichment balances out neuroinflammation on chronic pain and comorbid depression and anxiety disorders. British Journal of Pharmacology. doi:10.1111/bph.15584
NLM
Vieira LFK, Novaes LS, Picolo G, Munhoz CD, Cheung CW, Camarini R. How environmental enrichment balances out neuroinflammation on chronic pain and comorbid depression and anxiety disorders [Internet]. British Journal of Pharmacology. 2021 ;[citado 2024 jul. 06 ] Available from: https://doi.org/10.1111/bph.15584
Vancouver
Vieira LFK, Novaes LS, Picolo G, Munhoz CD, Cheung CW, Camarini R. How environmental enrichment balances out neuroinflammation on chronic pain and comorbid depression and anxiety disorders [Internet]. British Journal of Pharmacology. 2021 ;[citado 2024 jul. 06 ] Available from: https://doi.org/10.1111/bph.15584
Artigo de periodico
The Janus face of ouabain in Na+/K+‐ATPase and calcium signalling in neurons (2021)
Kinoshita, Paula Fernanda ; Orellana, Ana Maria Marques ; Nakao, Vinicius Watanabe ; Port's, Natacha Medeiros de Souza ; Quintas, Luis Eduardo Menezes ; Kawamoto, Elisa Mitiko ; Scavone, Cristoforo
Source: British Journal of Pharmacology. Unidade: ICB
Subjects: FARMACOLOGIA, ESTEROIDES, NEURÔNIOS, CÉREBRO, CÁLCIO, PROTEÍNAS DA MEMBRANA, MEMBRANA PLASMÁTICA, HOMEOSTASE, DOENÇAS NEURODEGENERATIVAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KINOSHITA, Paula Fernanda et al. The Janus face of ouabain in Na+/K+‐ATPase and calcium signalling in neurons. British Journal of Pharmacology, p. 1-13, 2021Tradução . . Disponível em: https://doi.org/10.1111/bph.15419. Acesso em: 06 jul. 2024.
APA
Kinoshita, P. F., Orellana, A. M. M., Nakao, V. W., Port's, N. M. de S., Quintas, L. E. M., Kawamoto, E. M., & Scavone, C. (2021). The Janus face of ouabain in Na+/K+‐ATPase and calcium signalling in neurons. British Journal of Pharmacology, 1-13. doi:10.1111/bph.15419
NLM
Kinoshita PF, Orellana AMM, Nakao VW, Port's NM de S, Quintas LEM, Kawamoto EM, Scavone C. The Janus face of ouabain in Na+/K+‐ATPase and calcium signalling in neurons [Internet]. British Journal of Pharmacology. 2021 ; 1-13.[citado 2024 jul. 06 ] Available from: https://doi.org/10.1111/bph.15419
Vancouver
Kinoshita PF, Orellana AMM, Nakao VW, Port's NM de S, Quintas LEM, Kawamoto EM, Scavone C. The Janus face of ouabain in Na+/K+‐ATPase and calcium signalling in neurons [Internet]. British Journal of Pharmacology. 2021 ; 1-13.[citado 2024 jul. 06 ] Available from: https://doi.org/10.1111/bph.15419
Artigo de periodico
Oxytocin and vasopressin: Signalling, behavioural modulation and potential therapeutic effects (2021)
Rae, Mariana Beu ; Duarte, Mariana Lemos ; Gomes, Ivone; Camarini, Rosana ; Devi, Lakshmi A.
Source: British Journal of Pharmacology. Unidade: ICB
Subjects: FARMACOLOGIA, ANSIEDADE, OCITOCINA, COMPORTAMENTO SOCIAL, VASOPRESSINAS, TRANSTORNOS DA ANSIEDADE, PEPTÍDEOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RAE, Mariana Beu et al. Oxytocin and vasopressin: Signalling, behavioural modulation and potential therapeutic effects. British Journal of Pharmacology, 2021Tradução . . Disponível em: https://doi.org/10.1111/bph.15481. Acesso em: 06 jul. 2024.
APA
Rae, M. B., Duarte, M. L., Gomes, I., Camarini, R., & Devi, L. A. (2021). Oxytocin and vasopressin: Signalling, behavioural modulation and potential therapeutic effects. British Journal of Pharmacology. doi:10.1111/bph.15481
NLM
Rae MB, Duarte ML, Gomes I, Camarini R, Devi LA. Oxytocin and vasopressin: Signalling, behavioural modulation and potential therapeutic effects [Internet]. British Journal of Pharmacology. 2021 ;[citado 2024 jul. 06 ] Available from: https://doi.org/10.1111/bph.15481
Vancouver
Rae MB, Duarte ML, Gomes I, Camarini R, Devi LA. Oxytocin and vasopressin: Signalling, behavioural modulation and potential therapeutic effects [Internet]. British Journal of Pharmacology. 2021 ;[citado 2024 jul. 06 ] Available from: https://doi.org/10.1111/bph.15481
Artigo de periodico
Sirtuins as pharmacological targets in neurodegenerative and neuropsychiatric disorders (2021)
Leite, Jefferson Antonio ; Nunes, Bruno Ghirotto ; Targhetta, Vitor Pedro ; Lima, Jean de ; Câmara, Niels Olsen Saraiva
Source: British Journal of Pharmacology. Unidades: ICB, FMRP
Subjects: IMUNOLOGIA, DOENÇA DE ALZHEIMER, TRANSTORNO AUTÍSTICO, TRANSTORNOS DO HUMOR, ESCLEROSE MÚLTIPLA, ESQUIZOFRENIA, DOENÇAS NEURODEGENERATIVAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LEITE, Jefferson Antonio et al. Sirtuins as pharmacological targets in neurodegenerative and neuropsychiatric disorders. British Journal of Pharmacology, v. 179, n. 8, p. 1496-1511, 2021Tradução . . Disponível em: https://doi.org/10.1111/bph.15570. Acesso em: 06 jul. 2024.
APA
Leite, J. A., Nunes, B. G., Targhetta, V. P., Lima, J. de, & Câmara, N. O. S. (2021). Sirtuins as pharmacological targets in neurodegenerative and neuropsychiatric disorders. British Journal of Pharmacology, 179( 8), 1496-1511. doi:10.1111/bph.15570
NLM
Leite JA, Nunes BG, Targhetta VP, Lima J de, Câmara NOS. Sirtuins as pharmacological targets in neurodegenerative and neuropsychiatric disorders [Internet]. British Journal of Pharmacology. 2021 ; 179( 8): 1496-1511.[citado 2024 jul. 06 ] Available from: https://doi.org/10.1111/bph.15570
Vancouver
Leite JA, Nunes BG, Targhetta VP, Lima J de, Câmara NOS. Sirtuins as pharmacological targets in neurodegenerative and neuropsychiatric disorders [Internet]. British Journal of Pharmacology. 2021 ; 179( 8): 1496-1511.[citado 2024 jul. 06 ] Available from: https://doi.org/10.1111/bph.15570
Artigo de periodico
A time-dependent contribution of hippocampal CB1, CB2 and PPARγ receptors to cannabidiol-induced disruption of fear memory consolidation (2020)
Raymundi, Ana Maria; Silva, Thiago R. da; Zampronio, Aleksander R.; Guimarães, Francisco Silveira ; Bertoglio, Leandro J.; Stern, Cristina A. J.
Source: British Journal of Pharmacology. Unidade: FMRP
Subjects: ANIMAIS, CANABINOIDES, FARMACOLOGIA, HIPOCAMPO, MEMÓRIA, RATOS WISTAR, RECEPTORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RAYMUNDI, Ana Maria et al. A time-dependent contribution of hippocampal CB1, CB2 and PPARγ receptors to cannabidiol-induced disruption of fear memory consolidation. British Journal of Pharmacology, v. 177, n. 4, p. 945-957, 2020Tradução . . Disponível em: https://doi.org/10.1111/bph.14895. Acesso em: 06 jul. 2024.
APA
Raymundi, A. M., Silva, T. R. da, Zampronio, A. R., Guimarães, F. S., Bertoglio, L. J., & Stern, C. A. J. (2020). A time-dependent contribution of hippocampal CB1, CB2 and PPARγ receptors to cannabidiol-induced disruption of fear memory consolidation. British Journal of Pharmacology, 177( 4), 945-957. doi:10.1111/bph.14895
NLM
Raymundi AM, Silva TR da, Zampronio AR, Guimarães FS, Bertoglio LJ, Stern CAJ. A time-dependent contribution of hippocampal CB1, CB2 and PPARγ receptors to cannabidiol-induced disruption of fear memory consolidation [Internet]. British Journal of Pharmacology. 2020 ; 177( 4): 945-957.[citado 2024 jul. 06 ] Available from: https://doi.org/10.1111/bph.14895
Vancouver
Raymundi AM, Silva TR da, Zampronio AR, Guimarães FS, Bertoglio LJ, Stern CAJ. A time-dependent contribution of hippocampal CB1, CB2 and PPARγ receptors to cannabidiol-induced disruption of fear memory consolidation [Internet]. British Journal of Pharmacology. 2020 ; 177( 4): 945-957.[citado 2024 jul. 06 ] Available from: https://doi.org/10.1111/bph.14895
Trabalho de evento-resumo periodico
Environmental enrichment and stress: how these factors affect BDNF gene expression in mouse prefrontal cortex (2020)
Silva, Nívea Karla de Gusmão Taveiros ; Costa, Gabriel de Araujo ; Priti, Chivers ; Bailey, Alexis ; Camarini, Rosana
Source: British Journal of Pharmacology. Conference titles: Conference Abstracts Selected Abstracts from Pharmacology. Unidade: ICB
Subjects: FARMACOLOGIA, CÓRTEX CEREBRAL DE ANIMAL, CAMUNDONGOS, ESTRESSE, EXPRESSÃO GÊNICA, FARMACOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Nívea Karla de Gusmão Taveiros et al. Environmental enrichment and stress: how these factors affect BDNF gene expression in mouse prefrontal cortex. British Journal of Pharmacology. Oxford: John Wiley & Sons, Inc. Disponível em: https://doi.org/10.1111/bph.15035. Acesso em: 06 jul. 2024. , 2020
APA
Silva, N. K. de G. T., Costa, G. de A., Priti, C., Bailey, A., & Camarini, R. (2020). Environmental enrichment and stress: how these factors affect BDNF gene expression in mouse prefrontal cortex. British Journal of Pharmacology. Oxford: John Wiley & Sons, Inc. doi:10.1111/bph.15035
NLM
Silva NK de GT, Costa G de A, Priti C, Bailey A, Camarini R. Environmental enrichment and stress: how these factors affect BDNF gene expression in mouse prefrontal cortex [Internet]. British Journal of Pharmacology. 2020 ; 177( 11): 2558.[citado 2024 jul. 06 ] Available from: https://doi.org/10.1111/bph.15035
Vancouver
Silva NK de GT, Costa G de A, Priti C, Bailey A, Camarini R. Environmental enrichment and stress: how these factors affect BDNF gene expression in mouse prefrontal cortex [Internet]. British Journal of Pharmacology. 2020 ; 177( 11): 2558.[citado 2024 jul. 06 ] Available from: https://doi.org/10.1111/bph.15035
Trabalho de evento-resumo periodico
Protracted environmental enrichment can alter gene expression but not methylation status on Bdnf gene promoter region in the prefrontal cortex (2020)
Costa, Gabriel de Araujo ; Priti, Chivers ; Silva, Nívea Karla de Gusmão Taveiros ; Bailey, Alexis ; Camarini, Rosana
Source: British Journal of Pharmacology. Conference titles: Selected Abstracts from Pharmacology. Unidade: ICB
Subjects: FARMACOLOGIA, CÓRTEX CEREBRAL DE ANIMAL, EXONS, EXPRESSÃO GÊNICA, EPIGÊNESE GENÉTICA, WESTERN BLOTTING, CAMUNDONGOS, COCAÍNA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COSTA, Gabriel de Araujo et al. Protracted environmental enrichment can alter gene expression but not methylation status on Bdnf gene promoter region in the prefrontal cortex. British Journal of Pharmacology. Oxford: John Wiley & Sons, Inc. Disponível em: https://doi.org/10.111/bph.15035. Acesso em: 06 jul. 2024. , 2020
APA
Costa, G. de A., Priti, C., Silva, N. K. de G. T., Bailey, A., & Camarini, R. (2020). Protracted environmental enrichment can alter gene expression but not methylation status on Bdnf gene promoter region in the prefrontal cortex. British Journal of Pharmacology. Oxford: John Wiley & Sons, Inc. doi:10.111/bph.15035
NLM
Costa G de A, Priti C, Silva NK de GT, Bailey A, Camarini R. Protracted environmental enrichment can alter gene expression but not methylation status on Bdnf gene promoter region in the prefrontal cortex [Internet]. British Journal of Pharmacology. 2020 ; 177( 11): 2582-2583.[citado 2024 jul. 06 ] Available from: https://doi.org/10.111/bph.15035
Vancouver
Costa G de A, Priti C, Silva NK de GT, Bailey A, Camarini R. Protracted environmental enrichment can alter gene expression but not methylation status on Bdnf gene promoter region in the prefrontal cortex [Internet]. British Journal of Pharmacology. 2020 ; 177( 11): 2582-2583.[citado 2024 jul. 06 ] Available from: https://doi.org/10.111/bph.15035
Artigo de periodico
A time-dependent contribution of hippocampal CB 1, CB 2 and PPARγ receptors to cannabidiol-induced disruption of fear memory consolidation (2020)
Raymundi, Ana Maria; Silva, Thiago R. da; Zampronio, Aleksander Roberto; Guimarães, Francisco Silveira ; Bertoglio, Leandro José; Stern, Cristina Aparecida Jark
Source: British Journal of Pharmacology. Unidade: FMRP
Subjects: CANABINOIDES, MEMÓRIA, MODELOS ANIMAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RAYMUNDI, Ana Maria et al. A time-dependent contribution of hippocampal CB 1, CB 2 and PPARγ receptors to cannabidiol-induced disruption of fear memory consolidation. British Journal of Pharmacology, v. 177, n. 4, p. 945-957, 2020Tradução . . Disponível em: https://doi.org/10.1111/bph.14895. Acesso em: 06 jul. 2024.
APA
Raymundi, A. M., Silva, T. R. da, Zampronio, A. R., Guimarães, F. S., Bertoglio, L. J., & Stern, C. A. J. (2020). A time-dependent contribution of hippocampal CB 1, CB 2 and PPARγ receptors to cannabidiol-induced disruption of fear memory consolidation. British Journal of Pharmacology, 177( 4), 945-957. doi:10.1111/bph.14895
NLM
Raymundi AM, Silva TR da, Zampronio AR, Guimarães FS, Bertoglio LJ, Stern CAJ. A time-dependent contribution of hippocampal CB 1, CB 2 and PPARγ receptors to cannabidiol-induced disruption of fear memory consolidation [Internet]. British Journal of Pharmacology. 2020 ; 177( 4): 945-957.[citado 2024 jul. 06 ] Available from: https://doi.org/10.1111/bph.14895
Vancouver
Raymundi AM, Silva TR da, Zampronio AR, Guimarães FS, Bertoglio LJ, Stern CAJ. A time-dependent contribution of hippocampal CB 1, CB 2 and PPARγ receptors to cannabidiol-induced disruption of fear memory consolidation [Internet]. British Journal of Pharmacology. 2020 ; 177( 4): 945-957.[citado 2024 jul. 06 ] Available from: https://doi.org/10.1111/bph.14895
Artigo de periodico
Enriching cancer pharmacology with drugs of marine origin (2020)
Jimenez, Paula C. ; Wilke, Diego Veras ; Branco, Paola Cristina; Bauermeister, Anelize ; Teixeira, Paula Rezende ; Gaudêncio, Susana P. ; Lotufo, Leticia Veras Costa
Source: British Journal of Pharmacology. Unidade: ICB
Subjects: FARMACOLOGIA, PRODUTOS NATURAIS, NEOPLASIAS, QUIMIOTERAPIA, QUIMIOTERÁPICOS, MEDICAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
JIMENEZ, Paula C. et al. Enriching cancer pharmacology with drugs of marine origin. British Journal of Pharmacology, v. 177, p. 3–27, 2020Tradução . . Disponível em: https://doi.org/10.1111/bph.14876. Acesso em: 06 jul. 2024.
APA
Jimenez, P. C., Wilke, D. V., Branco, P. C., Bauermeister, A., Teixeira, P. R., Gaudêncio, S. P., & Lotufo, L. V. C. (2020). Enriching cancer pharmacology with drugs of marine origin. British Journal of Pharmacology, 177, 3–27. doi:10.1111/bph.14876
NLM
Jimenez PC, Wilke DV, Branco PC, Bauermeister A, Teixeira PR, Gaudêncio SP, Lotufo LVC. Enriching cancer pharmacology with drugs of marine origin [Internet]. British Journal of Pharmacology. 2020 ; 177 3–27.[citado 2024 jul. 06 ] Available from: https://doi.org/10.1111/bph.14876
Vancouver
Jimenez PC, Wilke DV, Branco PC, Bauermeister A, Teixeira PR, Gaudêncio SP, Lotufo LVC. Enriching cancer pharmacology with drugs of marine origin [Internet]. British Journal of Pharmacology. 2020 ; 177 3–27.[citado 2024 jul. 06 ] Available from: https://doi.org/10.1111/bph.14876
Artigo de periodico
A proof‐of‐concept, phase 2 clinical trial of the gastrointestinal safety of a hydrogen sulfide‐releasing anti‐inflammatory drug (2020)
Wallace, John L. ; Nagy, Peter ; Feener, Troy D.; Allain, Thibault ; Ditrói, Tamás; Vaughan, David J.; Muscará, Marcelo Nicolás (Orientador) ; De Nucci, Gilberto ; Buret, Andre G.
Source: British Journal of Pharmacology. Unidade: ICB
Subjects: FARMACOLOGIA, ENSAIO CLÍNICO, ANTI-INFLAMATÓRIOS, SISTEMA GASTROINTESTINAL, MEDICAMENTO, ANALGÉSICOS, FÁRMACOS GASTRINTESTINAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WALLACE, John L. et al. A proof‐of‐concept, phase 2 clinical trial of the gastrointestinal safety of a hydrogen sulfide‐releasing anti‐inflammatory drug. British Journal of Pharmacology, n. 4, p. 769-777, 2020Tradução . . Disponível em: https://doi.org/10.1111/bph.14641. Acesso em: 06 jul. 2024.
APA
Wallace, J. L., Nagy, P., Feener, T. D., Allain, T., Ditrói, T., Vaughan, D. J., et al. (2020). A proof‐of‐concept, phase 2 clinical trial of the gastrointestinal safety of a hydrogen sulfide‐releasing anti‐inflammatory drug. British Journal of Pharmacology, ( 4), 769-777. doi:10.1111/bph.14641
NLM
Wallace JL, Nagy P, Feener TD, Allain T, Ditrói T, Vaughan DJ, De Nucci G, Buret AG. A proof‐of‐concept, phase 2 clinical trial of the gastrointestinal safety of a hydrogen sulfide‐releasing anti‐inflammatory drug [Internet]. British Journal of Pharmacology. 2020 ;( 4): 769-777.[citado 2024 jul. 06 ] Available from: https://doi.org/10.1111/bph.14641
Vancouver
Wallace JL, Nagy P, Feener TD, Allain T, Ditrói T, Vaughan DJ, De Nucci G, Buret AG. A proof‐of‐concept, phase 2 clinical trial of the gastrointestinal safety of a hydrogen sulfide‐releasing anti‐inflammatory drug [Internet]. British Journal of Pharmacology. 2020 ;( 4): 769-777.[citado 2024 jul. 06 ] Available from: https://doi.org/10.1111/bph.14641

USP Schools

ReP

Filtros

USP Schools

Departament

Authors

USP affiliated authors

Date published

Subjects

Conference titles

Funding Agencies

Indexado em

Normalized affiliation

Non normalized affiliation

Countries of institutions of collaboration